Serpin-resistant mutants of human tissue-type plasminogen activator

Nature
E L MadisonJ F Sambrook

Abstract

Tissue-type plasminogen activator (t-PA) converts the inactive zymogen, plasminogen, into the powerful protease, plasmin, which then degrades the fibrin meshwork of thrombi. To prevent systemic activation of plasminogen, plasma contains several inhibitors of t-PA, the most important of which is plasminogen activator inhibitor-1 (PAI-1), a member of the serpin superfamily. As the ability to produce serpin-resistant variants of t-PA could increase the potential of this enzyme as a thrombolytic agent, we have used the known three-dimensional structure of the complex between trypsin and bovine pancreatic trypsin inhibitor (BPTI) to model the interactions between the active site of human t-PA and PAI-1. On the basis of this model we then altered by site-directed mutagenesis those amino acids of t-PA predicted to make contact with PAI-1 but not with the substrate plasminogen. We report here that although the resulting mutants have enzymatic properties similar to those of wild-type t-PA, they display significant resistance to inhibition by PAI-1. For example, following incubation with an amount of the serpin that completely inhibits the wild-type enzyme, one variant retains 95% of its initial activity. This mutant is also resistant to...Continue Reading

References

Jun 1, 1977·European Journal of Biochemistry·B Wiman
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H E ShubeitaA M McCormick
Dec 1, 1986·The Journal of Clinical Investigation·D GinsburgT D Gelehrter
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T A Kunkel
Jan 1, 1983·Annual Review of Biochemistry·J Travis, G S Salvesen
Jan 1, 1984·Seminars in Thrombosis and Hemostasis·F Bachmann, I E Kruithof

❮ Previous
Next ❯

Citations

Jan 1, 1994·Journal of Clinical Pharmacology·L A Harker
Jan 1, 1991·Journal of Neuroscience Research·H Inouye, D A Kirschner
Jul 1, 1992·Medicinal Research Reviews·M D Walkinshaw
Apr 1, 1994·Protein Science : a Publication of the Protein Society·C L FisherJ H Griffin
May 1, 1996·Protein Science : a Publication of the Protein Society·B O VilloutreixO Teleman
Sep 1, 1990·Journal of Biotechnology·L Piérard, A Bollen
Sep 1, 1991·Journal of Molecular Graphics·P TufferyS Hazout
Jan 1, 1993·Biotechnology Advances·H R Lijnen, D Collen
Aug 1, 1991·Current Opinion in Biotechnology·A C Storer
May 1, 1991·Trends in Cardiovascular Medicine·M Schapira, P A Patston
Jan 1, 1991·Trends in Cardiovascular Medicine·D E Vaughan, J Loscalzo
May 1, 1992·Trends in Cardiovascular Medicine·I M LubinM S Runge
Mar 1, 1993·Trends in Cardiovascular Medicine·S W LeeD A Dichek
Nov 1, 1993·Trends in Cardiovascular Medicine·E Haber
Dec 1, 1995·Trends in Biotechnology·R A EnghA J Schulze
Nov 22, 2000·Biochimie·S BraudA Wisner
Dec 26, 2001·Current Opinion in Structural Biology·S Ye, E J Goldsmith
Dec 21, 2000·British Journal of Haematology·L A RobbieN A Booth
Aug 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·K M DunseM A Anderson
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J P EvansK A High
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·L A KuhnJ A Tainer
Jul 16, 2010·The Journal of Biological Chemistry·Likui YangAlireza R Rezaie
Jan 5, 2011·The Journal of Biological Chemistry·Zhonghui LinMingdong Huang
Aug 15, 1997·Nucleic Acids Research·S H Ke, E L Madison
Aug 23, 2002·Protein Science : a Publication of the Protein Society·Thomas SulikowskiPhilip A Patston
Apr 7, 2000·Protein Science : a Publication of the Protein Society·A VindigniE Di Cera
Mar 1, 1991·MNA Accent·K Barvels
Oct 1, 1994·Journal of Internal Medicine·H R LijnenS Thorsen
Dec 4, 1992·Annals of the New York Academy of Sciences·R Fears
Dec 4, 1992·Annals of the New York Academy of Sciences·H R Lijnen, D Collen
Dec 4, 1992·Annals of the New York Academy of Sciences·M OtterD C Rijken
Jan 26, 2010·American Journal of Respiratory Cell and Molecular Biology·Taher NassarAbd Al-Roof Higazi
Dec 1, 1994·The Journal of Clinical Investigation·E L Madison
Jun 28, 2000·Archives of Biochemistry and Biophysics·E F SanchezM Richardson
Apr 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·David T BergBryan E Jones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.